Sign in
4

Changes in Ownership

Tarsus Pharmaceuticals, Inc. Filed Acc 0002162845-26-000005

Options or other derivatives

  • Chief Commercial Officer acquired 17,265 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Clase Neera · Chief Commercial Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-11-03 Grant or award : show line 1 in the form Stock Option (right to buy) +10,587 10,587 D
2026-11-03 Grant or award : show line 2 in the form Restricted Stock Units +6,678 6,678 D
Loading xslF345X06/wk-form4_1793914818.xml…